Triochem Products Stock Screener | Share Price & Fundamental Analysis
TRIPR
Pharmaceuticals
Screen Triochem Products share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹0.40 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.04
EPS (TTM)
₹-16.33
Dividend Yield
-
Debt to Equity
-
52W High
-
52W Low
-
Operating Margin
-
Profit Margin
-100.00%
Revenue (TTM)
₹1.00
EBITDA
-
Net Income
₹-1.00
Total Assets
₹14.00
Total Equity
₹14.00
Triochem Products Share Price History - Stock Screener Chart
Screen TRIPR historical share price movements with interactive charts. Analyze price trends and patterns.
Triochem Products Company Profile - Fundamental Screener
Screen Triochem Products company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TRIPR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE331E01013
Triochem Products Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen TRIPR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 14 | 15 | 12 | 13 | 12 | 17 | 15 | 12 | 10 | 7 |
| Current Assets | 3 | 3 | 1 | 12 | 11 | 15 | 14 | 10 | 8 | 1 |
| Fixed Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Liabilities | ||||||||||
| Total Liabilities | 14 | 15 | 12 | 13 | 12 | 17 | 15 | 12 | 10 | 7 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 14 | 15 | 12 | 13 | 12 | 12 | 9 | 8 | 6 | 5 |
| Share Capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves & Surplus | 13 | 14 | 11 | 13 | 12 | 12 | 9 | 8 | 5 | 5 |
Screen TRIPR income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 1 | 0 | 9 | 14 | 21 | 12 | 35 | 18 | 23 | 31 |
| Expenses | 2 | 1 | 1 | 1 | 8 | 14 | 16 | 11 | 31 | 17 | 22 | 30 |
| EBITDA | 0 | 0 | 0 | -1 | 2 | 0 | 5 | 2 | 4 | 1 | 1 | 1 |
| Operating Profit % | 0.00% | 0.00% | 0.00% | 0.00% | 15.00% | -3.00% | 22.00% | 13.00% | 11.00% | 5.00% | 4.00% | 4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -1 | 0 | -1 | -1 | 2 | -1 | 5 | 1 | 4 | 1 | 1 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 |
| Net Profit | -1 | 0 | -1 | -1 | 1 | 0 | 3 | 1 | 3 | 1 | 0 | 0 |
| EPS | -23.90 | -16.33 | -41.36 | -36.12 | 53.99 | -18.24 | 138.89 | 30.33 | 104.29 | 23.51 | 13.94 | 16.98 |
Triochem Products Cash Flow Screener - Liquidity Fundamentals
Screen TRIPR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | -4 | -1 | 4 | 10 | 4 | -4 | 2 | -7 | 7 |
| Investing Activities | 0 | 3 | -10 | 0 | 0 | 0 | 0 | 0 | 4 | -4 |
| Financing Activities | 0 | 0 | 0 | 0 | -3 | -4 | 3 | -1 | 3 | -4 |
| Net Cash Flow | 0 | 0 | -11 | 4 | 8 | 0 | -1 | 1 | 0 | -1 |
Screen TRIPR shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 68.65% | 68.65% | 68.65% | 68.65% | 68.65% | 68.65% | 68.65% | 68.65% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 15.53% | 15.53% | 15.53% | 15.53% | 15.53% | 15.53% | 15.53% | 15.53% |
| Other Holding | 15.82% | 15.82% | 15.82% | 15.82% | 15.82% | 15.82% | 15.82% | 15.82% |
| Shareholder Count | 55 | 55 | 55 | 55 | 55 | 55 | 55 | 55 |
Triochem Products Dividend Screener - Share Yield Analysis
Screen TRIPR dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Triochem Products Index Membership - Market Screener Classification
Screen TRIPR by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Triochem Products Market Events Screener - Corporate Actions
Screen TRIPR market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | - |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | - |
| 2025-06-25 | 2025-06-25 | Annual General Meeting | NA | - |
| 2025-05-24 | 2025-05-24 | Quarterly Result Announcement | NA | - |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | - |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | - |
| 2024-08-22 | 2024-08-22 | Annual General Meeting | NA | - |
Triochem Products Competitors Screener - Peer Comparison
Screen TRIPR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 424,634 | 39.93 | 54,729 | 9.71% | 10,980 | 49.55 |
| Divis Laboratories | 172,860 | 69.20 | 9,712 | 18.67% | 2,191 | 56.33 |
| Torrent Pharmaceuticals | 129,151 | 60.10 | 11,539 | 6.99% | 1,911 | 61.47 |
| Cipla | 122,205 | 22.55 | 28,410 | 7.12% | 5,291 | 49.47 |
| Dr Reddys Laboratories | 107,114 | 18.60 | 33,741 | 16.73% | 5,725 | 60.05 |
| Lupin | 97,120 | 22.34 | 22,910 | 13.74% | 3,306 | 65.28 |
| Zydus Life Science | 92,392 | 18.40 | 23,511 | 18.55% | 4,615 | 40.07 |
| Mankind Pharma | 90,241 | 50.59 | 12,744 | 20.90% | 2,007 | 45.53 |
| Aurobindo Pharma | 71,119 | 20.79 | 32,346 | 9.43% | 3,484 | 59.88 |
| Alkem Laboratories | 67,243 | 27.59 | 13,458 | 3.70% | 2,216 | 49.80 |
Triochem Products Company Announcements - News Screener
Screen TRIPR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-28 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-12-28 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Submission Of Statement Of Deviation Or Variation In Public Issue Rights Issue Preferential Issue Etc. Under Regulation 32(1) Of The SEBI (Listing Obligation & Disclosures Requirement) Regulation 2015. | View |
| 2025-11-12 | Submission Of Unaudited Standalone Financial Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Wednesday 12Th November 2025 | View |
| 2025-11-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-05 | Board Meeting Intimation for The Quarter Ended 30Th September 2025 Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-04 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-10-24 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-10-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-16 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-16 | Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount For Loans Including Revolving Facilities Like Cash Credit From Banks / Financial Institutions | View |
| 2025-10-16 | Quarterly Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount On Loans From Banks / Financial Institutions And Unlisted Debt Securities | - |
| 2025-10-16 | Compliance-57 (5) : intimation after the end of quarter | View |
| 2025-10-15 | Board Meeting Intimation for Is Scheduled To Be Held On Friday 24Th October 2025 At The Registered Office Of The Company Situated At 4Th Floor Sambava Chambers Sir P. M. Road Fort Mumbai Maharashtra - 400 001 To Inter Alia Consider Following Business(Es): | View |
| 2025-09-29 | Compliance-57 (4) : Prior intimation to the beginning of the quarter | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-08-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |